AU2213197A – Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
– Google Patents
AU2213197A – Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
– Google Patents
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
Info
Publication number
AU2213197A
AU2213197A
AU22131/97A
AU2213197A
AU2213197A
AU 2213197 A
AU2213197 A
AU 2213197A
AU 22131/97 A
AU22131/97 A
AU 22131/97A
AU 2213197 A
AU2213197 A
AU 2213197A
AU 2213197 A
AU2213197 A
AU 2213197A
Authority
AU
Australia
Prior art keywords
nitric oxide
therapeutic methods
compositions useful
methods employing
useful therefor
Prior art date
1996-03-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22131/97A
Inventor
Ching-San Lai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medinox Inc
Original Assignee
Medinox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1996-03-05
Filing date
1997-03-05
Publication date
1997-09-22
1997-03-05
Application filed by Medinox Inc
filed
Critical
Medinox Inc
1997-09-22
Publication of AU2213197A
publication
Critical
patent/AU2213197A/en
Status
Abandoned
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K38/00—Medicinal preparations containing peptides
A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K39/00—Medicinal preparations containing antigens or antibodies
A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 – A61K41/00
A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P39/00—General protective or antinoxious agents
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P9/00—Drugs for disorders of the cardiovascular system
AU22131/97A
1996-03-05
1997-03-05
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
Abandoned
AU2213197A
(en)
Applications Claiming Priority (3)
Application Number
Priority Date
Filing Date
Title
US1282096P
1996-03-05
1996-03-05
US60012820
1996-03-05
PCT/US1997/004131
WO1997032585A1
(en)
1996-03-05
1997-03-05
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
Related Child Applications (1)
Application Number
Title
Priority Date
Filing Date
AU69984/98A
Division
AU722361B2
(en)
1995-11-21
1998-06-09
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
Publications (1)
Publication Number
Publication Date
AU2213197A
true
AU2213197A
(en)
1997-09-22
Family
ID=21756859
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
AU22131/97A
Abandoned
AU2213197A
(en)
1996-03-05
1997-03-05
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
Country Status (4)
Country
Link
JP
(1)
JP2000506170A
(en)
AU
(1)
AU2213197A
(en)
CA
(1)
CA2238029A1
(en)
WO
(1)
WO1997032585A1
(en)
Families Citing this family (14)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
ES2230581T3
(en)
*
1996-10-14
2005-05-01
Aventis Pharma Deutschland Gmbh
USE OF BRADIQUININE NON-PEPTIDIC ANTAGONISTS IN THE PREPARATION OF MEDICINES FOR THE TREATMENT AND PREVENTION OF ALZHEIMER’S DISEASE.
WO1999051215A2
(en)
*
1998-04-06
1999-10-14
Fujisawa Pharmaceutical Co., Ltd.
Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
EP1097927B1
(en)
*
1998-06-01
2006-07-19
Shionogi & Co., Ltd.
Cyanoiminoquinoxaline derivatives
US6596770B2
(en)
2000-05-05
2003-07-22
Medinox, Inc.
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
US6093743A
(en)
1998-06-23
2000-07-25
Medinox Inc.
Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
US6265420B1
(en)
1998-06-23
2001-07-24
Medinox, Inc.
Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide
GB9903404D0
(en)
*
1999-02-16
1999-04-07
Angiogene Pharm Ltd
Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
GB9908175D0
(en)
*
1999-04-09
1999-06-02
Lilly Co Eli
Method of treating neurological disorders
US6274627B1
(en)
1999-10-12
2001-08-14
Medinox, Inc.
Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor
US6271228B1
(en)
*
2000-04-28
2001-08-07
Pfizer Inc.
Blood pressure stabilization during hemodialysis
DE10230752A1
(en)
*
2002-07-09
2004-01-22
Boehringer Ingelheim Pharma Gmbh & Co. Kg
New drug compositions based on magnesium salts and fibrinolytics
AU2003259381A1
(en)
*
2002-08-29
2004-03-19
University Of Southampton
Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases
WO2008038302A2
(en)
*
2006-09-26
2008-04-03
Jegannathan Srinivas
Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger.
WO2009052376A1
(en)
2007-10-18
2009-04-23
Musc Foundation For Research Development
Methods for the diagnosis of genitourinary cancer
Family Cites Families (12)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US5426046A
(en)
*
1983-11-08
1995-06-20
The Board Of Trustees Of The Leland Stanford Junior University
Human monoclonal antibody to lipid A of gram negative bacteria
US5137889A
(en)
*
1983-12-02
1992-08-11
Otsuka Pharmaceutical Co., Ltd.
Dihydropyridine derivatives and process for preparing the same
US4686100A
(en)
*
1985-04-02
1987-08-11
The Board Of Trustees Of The Leland Stanford Junior University
Method for the treatment of adult respiratory distress syndrome
EP0391909B1
(en)
*
1987-09-03
1994-08-17
The University Of Georgia Research Foundation, Inc.
Ocular cyclosporin composition
US5294430A
(en)
*
1988-09-12
1994-03-15
University Of Rochester
Use of dithiocarbamates to treat myelosuppression
US5176908A
(en)
*
1988-12-19
1993-01-05
American Cyanamid Company
Method for the treatment of endotoxic shock in mammal
US5100899A
(en)
*
1989-06-06
1992-03-31
Roy Calne
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
US5530141A
(en)
*
1992-03-04
1996-06-25
Center For Innovative Technology
2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase
US5460954A
(en)
*
1992-04-01
1995-10-24
Cheil Foods & Chemicals, Inc.
Production of human proinsulin using a novel vector system
AU3803593A
(en)
*
1992-04-02
1993-11-08
Smithkline Beecham Corporation
Compounds
US5317040A
(en)
*
1993-01-26
1994-05-31
Washington University
Method for the treatment of pertussis with aminoguanidine
US5436265A
(en)
*
1993-11-12
1995-07-25
Merck Frosst Canada, Inc.
1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents
1997
1997-03-05
WO
PCT/US1997/004131
patent/WO1997032585A1/en
active
Application Filing
1997-03-05
JP
JP9532042A
patent/JP2000506170A/en
active
Pending
1997-03-05
CA
CA002238029A
patent/CA2238029A1/en
not_active
Abandoned
1997-03-05
AU
AU22131/97A
patent/AU2213197A/en
not_active
Abandoned
Also Published As
Publication number
Publication date
CA2238029A1
(en)
1997-09-12
WO1997032585A1
(en)
1997-09-12
JP2000506170A
(en)
2000-05-23
Similar Documents
Publication
Publication Date
Title
AU7678496A
(en)
1997-06-11
Combinational therapeutic methods employing nitric oxide scavengers
AU4479897A
(en)
1998-03-26
Compositions including r-nsaids and therapeutic and prophylactic methods employing said compositions
AU7819994A
(en)
1995-05-04
Nitric oxide treatment
AU7323294A
(en)
1995-02-13
Perfluoroelastomeric compositions and methods
GB2310855B
(en)
1999-10-27
Substituted phenylbisacylphosphine oxides and photoinitiator mixtures
AU5565599A
(en)
2000-03-06
Chemically modified saponins and the use thereof as adjuvants
AU3890297A
(en)
1998-02-25
Herbal formulation and therapeutic uses therefor
HK1045640A1
(en)
2002-12-06
Novel use of nitric oxide
AU2349399A
(en)
1999-08-16
R-lansoprazole compositions and methods
AU2213197A
(en)
1997-09-22
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
AU2972597A
(en)
1998-01-05
Compositions and uses thereof
AU8967998A
(en)
1999-09-15
Antibiotic-ligand conjugates and methods of use thereof
AU4215399A
(en)
2002-07-08
Dermatological compositions and methods
AU7401598A
(en)
1998-06-29
Epoxide-amine dendrimers and the preparation and use thereof
AU3624695A
(en)
1996-04-26
Method and device at primarily electrogastrography and electrourography
AU4006695A
(en)
1996-05-15
Calcineurin interacting protein compositions and methods
IL127152A0
(en)
1999-09-22
Methods of increasing nitric oxide synthesis
AU3674595A
(en)
1996-05-15
Antianemic agent containing iron and difructose
AU3118297A
(en)
1997-11-26
Sok-1 and methods of use
AU6528494A
(en)
1994-10-24
Nitric oxide combination therapy
AU3200197A
(en)
1998-01-07
New composition and methods
AU8473398A
(en)
1999-02-16
1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors
AU3634595A
(en)
1996-03-29
Bis-oxazolidines and their use
AU2529799A
(en)
1999-08-23
Benzofuran-4-carboxamides and their therapeutic use
AU1829097A
(en)
1997-08-11
Methods for regenerating scarless skin and compositions used therein
None